Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

OBJECTIVES: The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) program was initiated by the International Organization for the Study of Inflammatory Bowel Diseases (IOIBD). It examined potential treatment targets for inflammatory bowel disease (IBD) to be used for a "treat...

書誌詳細
主要な著者:	Peyrin-Biroulet, L, Sandborn, W, Sands, B, Reinisch, W, Bemelman, W, Bryant, R, D'Haens, G, Dotan, I, Dubinsky, M, Feagan, B, Fiorino, G, Gearry, R, Krishnareddy, S, Lakatos, P, Loftus, E, Marteau, P, Munkholm, P, Murdoch, T, Ordás, I, Panaccione, R, Riddell, R, Ruel, J, Rubin, D, Samaan, M, Siegel, C, Silverberg, MS, Stoker, J, Schreiber, S, Travis, S, Van Assche, G, Danese, S, Panes, J, Bouguen, G, O'Donnell, S, Pariente, B, Winer, S, Hanauer, S, Colombel, J
フォーマット:	Journal article
言語:	English
出版事項:	Nature Publishing Group 2015

類似資料

The Crohn's disease–ulcerative colitis clinical appraisal update: emerging trends in clinical practice
著者:: Sandborn, W, 等
出版事項: (2016)

Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process.
著者:: Peyrin-Biroulet, L, 等
出版事項: (2012)

Development of red flags index for early referral of adults with symptoms and signs suggestive of Crohn’s disease: an IOIBD initiative
著者:: Danese, S, 等
出版事項: (2015)

Development of an index to define overall disease severity in IBD
著者:: Siegel, C, 等
出版事項: (2016)

Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease.
著者:: D'Haens, G, 等
出版事項: (2009)

Biologic Therapies: From Complexity to Clinical Practice in a Changing Environment
著者:: Remo Panaccione, 等
出版事項: (2015-12-01)

Evolving concepts in Phase I and II Drug Development for Crohn's Disease.
著者:: Jairath, V, 等
出版事項: (2016)

Development of the Crohn's disease digestive damage score, the Lemann score.
著者:: Pariente, B, 等
出版事項: (2011)

Biomarker correlation with endoscopic outcomes in patients with Crohn's disease: data from CALM
著者:: Reinisch, W, 等
出版事項: (2018)

Evolving concepts in phases I and II drug development for Crohn's Disease
著者:: Jairath, V, 等
出版事項: (2016)

Standardizing scoring conventions for Crohn’s disease endoscopy: An international RAND/UCLA appropriateness study
著者:: Khanna, R, 等
出版事項: (2023)

The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis
著者:: Travis, S, 等
出版事項: (2013)

Biosimilars in IBD: hope or expectation?
著者:: Gecse, K, 等
出版事項: (2013)

Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus
著者:: Vuitton, L, 等
出版事項: (2017)

American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.
著者:: Clark, M, 等
出版事項: (2007)

A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.
著者:: Gasche, C, 等
出版事項: (2000)

Reliability and initial validation of the ulcerative colitis endoscopic index of severity.
著者:: Travis, S, 等
出版事項: (2013)

The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS].
著者:: Travis, S, 等
出版事項: (2015)

Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial
著者:: Panaccione, R, 等
出版事項: (2019)

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS).
著者:: Travis, S, 等
出版事項: (2012)

Review article: defining remission in ulcerative colitis.
著者:: Travis, S, 等
出版事項: (2011)

European evidence-based Consensus on the management of ulcerative colitis: Current management.
著者:: Travis, S, 等
出版事項: (2008)

Shorter Crohn’s Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 Studies
著者:: Laurent Peyrin-Biroulet, 等
出版事項: (2024-01-01)

Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies.
著者:: Sandborn, W, 等
出版事項: (2015)

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.
著者:: Colombel, J, 等
出版事項: (2017)

CORE-IBD: a multidisciplinary international consensus initiative to develop a core outcome set for randomized controlled trials in inflammatory bowel disease
著者:: Ma, C, 等
出版事項: (2022)

Effect of adalimumab dose escalation on clinical, health-related quality of life, treatment satisfaction and work productivity outcomes among patients with ulcerative colitis in a clinical practice setting: results from INSPIRADA
著者:: Travis, S, 等
出版事項: (2017)

Effect of adalimumab on extraintestinal manifestations among patients with ulcerative colitis in a clinical practice setting: results from INSPIRADA
著者:: Travis, S, 等
出版事項: (2017)

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?
著者:: D'Haens, G, 等
出版事項: (2011)

The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safety.
著者:: Van Assche, G, 等
出版事項: (2011)

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study.
著者:: Travis, S, 等
出版事項: (2014)

Budesonide MMX® for the induction of remission of mild to moderate ulcerative colitis: a pooled safety analysis.
著者:: Lichtenstein, G, 等
出版事項: (2015)

Lymphoma risk and overall safety profile of Adalimumab in patients with Crohn's disease with up to 6 years of follow-up in the pyramid
著者:: D'Haens, G, 等
出版事項: (2018)

Endoscopic and deep remission at 1 year prevents disease progression in early Crohn’s disease: long-term data from CALM
著者:: Yzet, C, 等
出版事項: (2019)

Central Reading of Endoscopy Endpoints in Inflammatory Bowel Disease Trials.
著者:: Gottlieb, K, 等
出版事項: (2015)

The real-world global use of patient-reported outcomes for the care of patients with inflammatory bowel disease
著者:: Horrigan, JM, 等
出版事項: (2023)

Benzimidazoles promote anti-TNF mediated induction of regulatory macrophages and enhance therapeutic efficacy in a murine model
著者:: Wildenberg, M, 等
出版事項: (2017)

Antieosinophil Therapeutics
著者:: Straumann, A, 等
出版事項: (2013)

Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis
著者:: Samaan, MA, 等
出版事項: (2018)

Effect of adalimumab on clinical outcomes and health-related quality of life among patients with ulcerative colitis in a clinical practice setting: Results from inspirADA
著者:: Travis, S, 等
出版事項: (2017)